145 related articles for article (PubMed ID: 20155722)
21. Natural history and treatment of renal involvement in Fabry disease.
Branton M; Schiffmann R; Kopp JB
J Am Soc Nephrol; 2002 Jun; 13 Suppl 2():S139-43. PubMed ID: 12068026
[No Abstract] [Full Text] [Related]
22. Fabry disease: characterization of alpha-galactosidase A double mutations and the D313Y plasma enzyme pseudodeficiency allele.
Yasuda M; Shabbeer J; Benson SD; Maire I; Burnett RM; Desnick RJ
Hum Mutat; 2003 Dec; 22(6):486-92. PubMed ID: 14635108
[TBL] [Abstract][Full Text] [Related]
23. [Nephropathy in a case of Fabry's disease].
Reyes Marín FA; Gómez Navarro B; Tamayo y Orozco J; Larriva Sahd J; Hernández Pando R; Velázquez Forero F; Peña JC
Rev Invest Clin; 1991; 43(4):373-6. PubMed ID: 1665922
[TBL] [Abstract][Full Text] [Related]
24. Molecular genetic analysis of a Chinese patient with Fabry disease.
Lam CW; Mak YT; Lo YM; Tong SF; To KF; Lai FM
Chin Med J (Engl); 2000 Feb; 113(2):186-8. PubMed ID: 11775551
[No Abstract] [Full Text] [Related]
25. Simultaneous multicystic kidney and Anderson-Fabry disease: 2 separate entities or same side of the coin.
Pisani A; Riccio E; Cianciaruso B; Imbriaco M
J Nephrol; 2011; 24(6):806-8. PubMed ID: 22058028
[TBL] [Abstract][Full Text] [Related]
26. Identification of a novel point mutation (S65T) in alpha-galactosidase A gene in Chinese patients with Fabry disease. Mutations in brief no. 169. Online.
Chen CH; Shyu PW; Wu SJ; Sheu SS; Desnick RJ; Hsiao KJ
Hum Mutat; 1998; 11(4):328-30. PubMed ID: 9554750
[TBL] [Abstract][Full Text] [Related]
27. Fabry disease: D313Y is an alpha-galactosidase A sequence variant that causes pseudodeficient activity in plasma.
Froissart R; Guffon N; Vanier MT; Desnick RJ; Maire I
Mol Genet Metab; 2003 Nov; 80(3):307-14. PubMed ID: 14680977
[TBL] [Abstract][Full Text] [Related]
28. Molecular analysis in Fabry disease in Spain: fifteen novel GLA mutations and identification of a homozygous female.
Rodríguez-Marí A; Coll MJ; Chabás A
Hum Mutat; 2003 Sep; 22(3):258. PubMed ID: 12938095
[TBL] [Abstract][Full Text] [Related]
29. Molecular basis of Fabry disease: mutations and polymorphisms in the human alpha-galactosidase A gene.
Eng CM; Desnick RJ
Hum Mutat; 1994; 3(2):103-11. PubMed ID: 7911050
[TBL] [Abstract][Full Text] [Related]
30. A case of Fabry's disease.
Miura M; Tomino Y; Inoue W; Endoh M; Suga T; Kaneshige H; Nomoto Y; Sakai H; Matsuo I; Nagura H; Ikeda N
Tokai J Exp Clin Med; 1983 Jan; 8(1):23-9. PubMed ID: 6310828
[TBL] [Abstract][Full Text] [Related]
31. Fabry-like laminated myelin body associated with IgA nephropathy.
Yoshida A; Morozumi K; Takeda A; Koyama K; Oikawa T
Nihon Jinzo Gakkai Shi; 1994 Nov; 36(11):1303-7. PubMed ID: 7853764
[TBL] [Abstract][Full Text] [Related]
32. The ultrastructural changes in renal biopsy compatible with Fabry's disease. Case report.
Wagrowska-Danilewicz M; Danilewicz M; Goździk Z
Pol J Pathol; 1999; 50(1):61-3. PubMed ID: 10412277
[TBL] [Abstract][Full Text] [Related]
33. [Fabry nephropathy in a female with superposed IgA glomerulonephritis].
Pisani A; Sessa A; Sabbatini M; Andreucci MV; Fusco C; Balletta M; Cianciaruso B
G Ital Nefrol; 2005; 22(4):385-9. PubMed ID: 16267800
[TBL] [Abstract][Full Text] [Related]
34. Fabry disease: twenty-two novel mutations in the alpha-galactosidase A gene and genotype/phenotype correlations in severely and mildly affected hemizygotes and heterozygotes.
Ashton-Prolla P; Tong B; Shabbeer J; Astrin KH; Eng CM; Desnick RJ
J Investig Med; 2000 Jul; 48(4):227-35. PubMed ID: 10916280
[TBL] [Abstract][Full Text] [Related]
35. Atypical Fabry's disease. An oligosymptomatic variant.
Ko YH; Kim HJ; Roh YS; Park CK; Kwon CK; Park MH
Arch Pathol Lab Med; 1996 Jan; 120(1):86-9. PubMed ID: 8554452
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of fabry disease in a cohort of 508 unrelated patients with hypertrophic cardiomyopathy.
Monserrat L; Gimeno-Blanes JR; Marín F; Hermida-Prieto M; García-Honrubia A; Pérez I; Fernández X; de Nicolas R; de la Morena G; Payá E; Yagüe J; Egido J
J Am Coll Cardiol; 2007 Dec; 50(25):2399-403. PubMed ID: 18154965
[TBL] [Abstract][Full Text] [Related]
37. Megadolichobasilar anomaly with thrombosis in a family with Fabry's disease and a novel mutation in the alpha-galactosidase A gene.
Garzuly F; Maródi L; Erdös M; Grubits J; Varga Z; Gelpi E; Rohonyi B; Mázló M; Molnár A; Budka H
Brain; 2005 Sep; 128(Pt 9):2078-83. PubMed ID: 15947062
[TBL] [Abstract][Full Text] [Related]
38. A novel mutation (E358K) in the alpha-galactosidase A gene detected in a Japanese family with Fabry disease.
Miyazaki T; Kajita M; Ohmori S; Mizutani N; Niwa T; Murata Y; Seo H
Hum Mutat; 1998; Suppl 1():S139-40. PubMed ID: 9452068
[No Abstract] [Full Text] [Related]
39. Renal involvement in an Anderson-Fabry heterozygote.
Kingdon EJ; Holt SG; Burns A
Postgrad Med J; 2002 Dec; 78(926):759. PubMed ID: 12509698
[No Abstract] [Full Text] [Related]
40. A nonsense mutation (R220X) in the alpha-galactosidase A gene causes typical Fabry disease in both genders.
Maki N; Komatsuda A; Wakui H; Oyama Y; Kodama T; Ohtani H; Kigawa A; Aiba N; Imai H; Motegi M; Yamaguchi A; Sawada K
Clin Nephrol; 2004 Mar; 61(3):185-90. PubMed ID: 15077869
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
